Histopathology grading in small breast cancers ≤ 10 mm - Results from an area with mammography screening

Breast Cancer Research and Treatment

Volumn 44, Issue 1, 1997, Pages 39-46

  Arnesson, Lars Gunnar ^a   Hatschek, Thomas ^a   Smeds, Staffan ^a   Gröntoft, Otto ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Breast neoplasm; Grading; Pathology; Screening

Indexed keywords

RECEPTOR;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER RECURRENCE; CANCER SURVIVAL; CELL CYCLE S PHASE; CLASSIFICATION; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIFE TABLE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; TRAINING; TREATMENT PLANNING; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMAGE CYTOMETRY; LYMPH NODES; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RECURRENCE;

EID: 0030936898     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005887412494     Document Type: Article

References (32)

1. Fagerberg G, Baldetorp L, Gröntoft O, Lundström B, Månson JC, Nordenskjöld B: Effects of repeated mammographic screening on breast cancer stage distribution. Results from a randomised study of 92934 women in a Swedish county. Acta Radiol Oncol 24: 465-473, 1985
2. Tabar L, Fagerberg G, Gad A, et al: Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet i: 829-832, 1985
3. Bloom H, Richardson W: Histological grading and prognosis in breast cancer. Br J Cancer 11:359-377, 1957
4. Fisher E, Anderson S, Redmond C, Fisher B: Pathological findings from the National Surgical Adjuvant Breast Project Protocol B-06. 10-year pathologic and clinical prognostic discriminants. Cancer 71:2507-2514, 1993
5. Duffy SW, Tabar L, Fagerberg G, Gad A, Gröntoft O, South MC, Day NE: Breast screening, prognostic factors and survival - results from the Swedish two county study. Br J Cancer 64:1133-1138, 1991
6. Gilchrist K, Kalish L, Gould V, et al: Interobserver reproducibility of histopathological features in stage II breast cancer. An ECOG Study. Breast Cancer Res Treat 5:3-10, 1985
7. Arnesson LG, Smeds S, Hatschek T, Nordenskjöld B, Fagerberg G: Hormone receptors, ploidy and proliferation rate in breast cancers up to 10 mm. Eur J Surg Oncol 18:235-240, 1992
8. Scarff RW, Torloni H: Histological typing of breast tumours. In: World Health Organisation: International Histological Classification of Tumours, No 2. WHO, Geneva, 1968
9. Risberg B, Stål O, Bjelkenkrantz K, Hatschek T, Franzen G, Arvidsson S, Nordenskjöld B: Use of formalin fixed, paraffin embedded tumours for estimation of cellular DNA content and S-phase fraction by static cytofluorometry. Acta Radiol Oncol 24:537-544, 1985
10. Wrange Ö, Nordenskjöld B, Gustafsson JÅ: Cytosol estradiol receptor in human mammary carcinoma: an assay based on isoelectric focusing in polyacrylamide gel. Anal Biochem 85:461-475, 1978
11. Wrange Ö, Humla S, Ramberg I, Gustafsson S, Skoog L, Nordenskjöld B, Gustafsson JÅ: Progestin-receptor analysis in human breast cancer cytosol by electric focusing in slabs of polyacrylamide gel. J Steroid Biochem 14:141-148, 1981
12. Anderson TJ, Lamb J, Donnan P, et al: Comparative pathology of breast cancer in a randomised trial of screening. Br J Surg 64:108-113, 1991
13. Hatschek T, Fagerberg G, Stål O, Sullivan S, Carstensen J, Gröntoft O, Nordenskjöld B: Cytometric characterization and clinical course of breast cancer diagnosed in a population based screening program. Cancer 64:1074-1081, 1989
14. Kallioniemi O-P, Hietanen T, Mattila J, Lehtinen M, Lauslahti K, Koivula T: Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer. Eur J Cancer Clin Oncol 23:277-278, 1987
15. Frierson HF Jr: Grade and flow cytometric analysis of ploidy for infiltrating ductal carcinomas. Hum Pathol 24:24-29, 1993
16. Azavedo E, Fallenius A, Svane G, Auer G: Nuclear DNA content, histological grade and clinical course in patients with nonpalpable mammographically detected breast adenocarcinomas. Am J Clin Oncol 13:23-27, 1990
17. Dowle CS, Owainati A, Robins A, Burns K, Ellis IO, Elston CW, Blarney R: Prognostic significance of the DNA content of human breast cancer. Br J Surg 74: 133-136, 1987
18. Fisher E, Redmond C, Liu H, Rockette H, Fisher B: Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer. Cancer 45: 349-353, 1980
19. Pagana T, Lubbe W, Schwartz S, Sprechini G: A comparison of palpable and nonpalpable breast cancers. Arch Surg 124:26-28, 1989
20. Joensuu H, Toikkanen S: Prognosis of breast cancer with small primary tumor (pT1). Acta Oncol 30: 793-796, 1991
21. Tubiana M, Koscielny S: Natural history of human breast cancer: Recent data and clinical implications. Breast Cancer Res Treat 18:125-140, 1991
22. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403-410, 1991
23. Grönoft O: Staging and grading of invasive ductal carcinoma in a randomized population screened by mammography: The first and second screens. In: Day NE, Miller AB (eds) Screening for Breast Cancer. Hans Huber Publishers, Toronto, 1988, pp 79-82
24. Harvey JM, de Klerk NH, Sterrett GF: Histological grading in breast cancer: interobserver agreement, and relation to other prognostic factors including ploidy. Pathology 24:63-68, 1992
25. Fisher E: Comment on "Interobserver reproducibility of histopathological features in Stage II breast cancer", by KW Gilchrist et al. Breast Cancer Res Treat 5:11-13, 1985
26. Dalton L, Page D, Dupont W: Histologic grading of breast cancer. A reproducibility study. Cancer 73: 2765-2770, 1994
27. Parham DM, Hagen N, Brown RA: Simplified method of grading primary carcinomas of the breast. J Clin Pathol 45:517-520, 1992
28. Rank F, Dombernowsky P, Bang-Jespersen N, Vestergaard Pedersen B, Keiding N: Histologic malignancy grading of invasive ductal breast carcinoma. A regression analysis of prognostic factors in low-risk carcinomas from a multicenter trial. Cancer 60: 1299-1305, 1987
29. Stierer M, Rosen H, Weber R: Nuclear pleomorphism, a strong prognostic factor in axillary node-negative small invasive breast cancer. Breast Cancer Res Treat 20:109-116, 1992
30. Stierer M, Rosen HR, Weber R, Marczell A, Kornek GV, Czerwenka E: Long term analysis of factors influencing the outcome in carcinoma of the breast smaller than one centimeter. Surg Gynecol Obstet 175:151-160, 1992
31. Galea M, Blarney R, Ellis I, Elston C: The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 22:207-220, 1992
32. Brown J, Benson A, Jones M: Confirmation of a long-term prognostic index in breast cancer. The Breast 2: 144-147, 1993